Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials—TAP report 1. Arch Ophthalmol 1999; 117: 1329–1345.
2. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001; 131: 541–560.
3. Scientific Department, Royal College of Ophthalmologists. Ranibizumab: the clinician's guide to commencing, continuing and discontinuing treatment. Royal College Ophthalmol 2008. http://www.rcophth.ac.uk/docs/scientific/Ranibizumab_-_June_2008.pdf .
4. Scientific Department, Royal College of Ophthalmologists. Commissioning contemporary AMD Services: a guide for commissioners and clinicians. Version 3. Royal College Ophthalmol 2007. http://www.rcophth.ac.uk/docs/publications/published-guidelines/CommissionContempAMDServicesV3Final.pdf .
5. National Institute for Health and Clinical Excellence. Macular degeneration (age-related)—pegaptanib and ranibizumab: final appraisal determination. 2009. http://www.nice.org.uk/nicemedia/pdf/AMDFAD.pdf . Accessed 17 August 2009.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献